Enliven Therapeutics Inc.

21.02
-0.27 (-1.27%)
At close: Jan 28, 2025, 2:15 PM

Enliven Therapeutics Inc. Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ELVN stock have an median target of 37, with a low estimate of 34 and a high estimate of 42. The median target predicts an increase of 76.02% from the current stock price of 21.02.

Analyst Consensus: Buy
Target Low Average Median High
Price $34 $37.8 $37 $42
Change 61.75% 79.83% 76.02% 99.81%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Enli... Unlock content with Pro Subscription

Updated Oct 01, 2024

Rating Apr 24Jun 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 000000
Buy 111211
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 2 1 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
8.33K
from 0
Increased by -%
EPS This Year
-1.91
from -2.01
Increased by 5.0%
EPS Next Year
-2.28
from -1.91
Increased by -19.4%